FREE Shipping: All Individuals in United States, Mexico, Central and South America & The Caribbean
Novel Therapies in Hepatitis C Virus, An Issue of Clinics in Liver Disease
Paul J. Pockros, MD
Please call 1-800-545-2522 for availability
The Guest Editor presents state-of-the-art articles devoted to therapies for treatment of HCV. The novel therapies addressed in this issue include interferons, viral kinetics and anti-viral resistence, anti-fibrotics, immunotherapeutics, hepatoprotectants and caspace inhibitors, and cyclosporine analogues, to name a few.
Elsevier is a leading publisher of health science books and journals, helping to advance medicine by delivering superior education, reference information and decision support tools to doctors, nurses, health practitioners and students. With titles available across a variety of media—print, online and mobile, we are able to supply the information you need in the most convenient format.